Immunic, Inc. SEC filings IMUX
Immunic, Inc. has 832 filings in SEC EDGAR's recent list, going back to Feb 18, 2004. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 4, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2026 | — |
| D | Filing | Mar 4, 2026 | — |
| EFFECT | Filing | May 31, 2024 | — |
| CORRESP | Letter to the SEC | May 29, 2024 | — |
| EFFECT | Filing | Apr 30, 2024 | — |
| CORRESP | Letter to the SEC | Apr 26, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 21, 2024 | — |
| D | Filing | Jan 19, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2023 | — |
| EFFECT | Filing | Dec 20, 2022 | — |
| CORRESP | Letter to the SEC | Dec 16, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2022 | — |
| D | Filing | Oct 18, 2022 | — |
| EFFECT | Filing | May 5, 2021 | — |
| CORRESP | Letter to the SEC | May 3, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2021 | — |
| EFFECT | Filing | Nov 24, 2020 | — |
| CORRESP | Letter to the SEC | Nov 20, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2020 | — |
| SEC STAFF LETTER | Filing | Mar 2, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 10, 2020 | — |
| 425 | Filing | Apr 2, 2019 | — |
| 425 | Filing | Mar 14, 2019 | — |
| 425 | Filing | Feb 28, 2019 | — |
| 425 | Filing | Feb 26, 2019 | — |
| EFFECT | Filing | Feb 14, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2019 | — |
| CORRESP | Letter to the SEC | Feb 13, 2019 | — |
| 425 | Filing | Feb 6, 2019 | — |
| 425 | Filing | Jan 7, 2019 | — |
| 425 | Form 8-k | Jan 7, 2019 | — |
| EFFECT | Filing | Jun 13, 2018 | — |
| CORRESP | Letter to the SEC | Jun 11, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2018 | — |
| CORRESP | Letter to the SEC | Jun 8, 2018 | — |
| EFFECT | Filing | May 26, 2015 | — |
| EFFECT | Filing | Oct 2, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2014 | — |
| EFFECT | Filing | Apr 16, 2014 | — |
| CORRESP | Letter to the SEC | Apr 14, 2014 | — |
| CORRESP | Letter to the SEC | Apr 14, 2014 | — |
| CORRESP | Letter to the SEC | Apr 8, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2014 | — |
| CORRESP | Letter to the SEC | Apr 3, 2014 | — |
| CORRESP | Letter to the SEC | Apr 3, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 2, 2014 | — |
| D/A | Filing | Mar 7, 2014 | — |
| D | Filing | Feb 4, 2014 | — |
| D/A | Filing | Jan 31, 2014 | — |
| CERTNAS | Auto-generated paper document | Nov 19, 2013 | — |
| CORRESP | Letter to the SEC | Nov 18, 2013 | — |
| CORRESP | Letter to the SEC | Nov 18, 2013 | — |
| 8-A12B | Filing | Nov 15, 2013 | — |
| CORRESP | Letter to the SEC | Nov 1, 2013 | — |
| CORRESP | Letter to the SEC | Oct 30, 2013 | — |
| CORRESP | Letter to the SEC | Oct 25, 2013 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2013 | — |
| CORRESP | Letter to the SEC | Oct 11, 2013 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2013 | — |
| DRSLTR | Filing | Aug 30, 2013 | — |
| DRS/A | Filing | Aug 30, 2013 | — |
| UPLOAD | Letter from the SEC | Aug 21, 2013 | — |
| DRSLTR | Filing | Jul 22, 2013 | — |
| DRS | Filing | Jul 22, 2013 | — |
| D/A | Filing | Jun 24, 2013 | — |
| D | Filing | Mar 14, 2013 | — |
| D/A | Filing | Nov 7, 2012 | — |
| D | Filing | Oct 9, 2012 | — |
| D | Filing | Jun 22, 2012 | — |
| D | Filing | Feb 17, 2012 | — |
| D | Filing | Jun 23, 2011 | — |
| D/A | Filing | Jun 22, 2011 | — |
| D/A | Filing | Feb 7, 2011 | — |
| D/A | Filing | Jan 4, 2011 | — |
| D/A | Filing | Oct 15, 2010 | — |
| D/A | Filing | Jul 1, 2010 | — |
| D/A | Filing | Jun 23, 2010 | — |
| D/A | Filing | May 14, 2010 | — |
| D/A | Filing | Mar 18, 2010 | — |
| D/A | Filing | Dec 10, 2009 | — |
| D/A | Filing | Oct 28, 2009 | — |
| D | Filing | Oct 7, 2009 | — |
| REGDEX | Auto-generated paper document | Sep 14, 2007 | — |
| REGDEX/A | Auto-generated paper document | Feb 14, 2006 | — |
| REGDEX | Auto-generated paper document | Oct 28, 2005 | — |
| REGDEX | Auto-generated paper document | Feb 10, 2005 | — |
| REGDEX/A | Auto-generated paper document | Jun 7, 2004 | — |
| REGDEX | Auto-generated paper document | Feb 18, 2004 | — |
Showing 90 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMUX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, United States
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1280776
- Former names
- VITAL THERAPIES INC (until Apr 10, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.